Why Broadcom Stock Dipped Into the red Today

Broadcom (AVGO) slid almost 1% after Erste Group downgraded the stock to Hold from Buy, citing valuation concerns (e.g., price/sales above 23) despite bullish views on its custom AI chip business. The shares were also pressured by a Reuters report that DeepSeek is reportedly developing its own proprietary AI chip, reinforcing competitive risk from potential in-house alternatives to third-party “chippies.” Net: near-term sentiment is cautious, with upside seen as potentially capped by rich multiples even as AI hardware demand remains strong.

Analysis

The near-term damage here is mostly to sentiment and multiple support, not to the revenue line. A stock priced for durable AI share gains can absorb a few quarters of noise, but once the market starts to believe customers will internalize more silicon, the valuation haircut can come before any fundamental slowdown shows up.

The second-order effect is that “chip substitution” does not mean AI capex disappears; it changes where the margin pool accrues. If large customers move even part of the workload in-house, Broadcom’s design-intellectual-property economics become less scarce, while foundry, advanced packaging, and EDA names keep the spend. NVDA is the cleaner relative winner if the market concludes proprietary chips are poor substitutes for training and software-stack depth.

Contrarian take: the market may be overreacting to a project announcement that is more negotiating tactic than production threat. Most custom AI efforts stall on power, yield, packaging, and software integration, so the real tell is not the headline but whether AI bookings and gross margin stay intact over the next 1-2 quarters. The thesis breaks if Broadcom’s AI revenue guide decelerates materially or if another major buyer publicly commits to an internal chip program within a quarter or two.

Key Decisions for Investors

• Do not chase a fresh short in AVGO on this news alone; wait 2-4 weeks for either a better entry on a larger drawdown or confirmation of slower AI bookings. If the stock falls another 5-7% without a guidance cut, a tactical long is viable for mean reversion.
• Relative-value trade: long NVDA / short AVGO for 1-3 months to hedge against custom-ASIC substitution risk. Best if the market starts rewarding software-lock-in over merchant silicon; cover if AVGO maintains AI growth and margin expansion.
• For existing AVGO longs, consider a 2-3 month put spread rather than an outright sale if implied volatility remains modest. Use it as a valuation hedge; abandon the hedge if management reaffirms AI demand and gross margin trajectory.
• Watch TSM, AMAT, and ASML as the likely spillover beneficiaries if custom-chip adoption rises. A pick-up in their capex commentary would confirm the mechanism before it shows up in AVGO fundamentals.